|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 奥替康唑>> 市场分析报告 |
奥替康唑市场分析报告 |
|
Vulvovaginal candidiasis - Pipeline Insight, 2021 ... candidiasis Emerging Drugs Oteseconazole: Mycovia Pharmaceuticals Oteseconazole (VT-1161) is a novel ... recurrent vulvovaginal candidiasis (RVVC). Oteseconazole is designed with the ... currently available antifungal agents. Oteseconazole received FDA Qualified ... 14-alpha demethylase inhibitors - Pipeline Insight, 2022 ... Inhibitors Emerging Drugs Oteseconazole: Mycovia Pharmaceuticals Oteseconazole (VT-1161) is a novel ... recurrent vulvovaginal candidiasis (RVVC). Oteseconazole is designed with the ... SMB ProFem Key Products Oteseconazole Isavuconazonium Miconazole ZP 059 PC-945 ... Non Hormonal Contraceptives Market for Women’s Health by Target Indication (Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis and Others), Type of Molecule (Biologic and Small Molecule), Purpose of Therapy (Treatment of Disease and Management of Symptoms), Mechanism of Action (Antagonist, Agonist, Inhibitor and Modulator), Route of Administration (intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal and others), and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2021-2030 The non hormonal contraceptives market is expected to reach USD 1.8 billion in 2021 and anticipated to grow at a CAGR of 22% during the forecast period 2021-2030. According to the World Health Organization (WHO), around one-third of clinical conditions ... Coccidioidomycosis - Pipeline Review, H1 2020 Coccidioidomycosis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H1 2020, provides an overview of the Coccidioidomycosis (Infectious Disease) ... Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021 Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis - Drugs in Development, 2021, provides an overview of the ... Onychomycosis (Tinea Unguium) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Onychomycosis (Tinea Unguium) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Drugs in ... Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Drugs In Development, 2022, provides an ... Vaginitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major vaginitis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.49% during 2024-2034. The vaginitis market has been ... Vulvovaginal Candidiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major vulvovaginal candidiasis markets reached a value of US$ 734.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,058.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.37% during 2024-2034. The vulvovaginal ... Germany Generative AI in Chemical Market Assessment, By Model [Deep Learning, Natural Language Processing, Discriminative Model, Reinforcement Learning, Others], By Application [Complex Structure Predictions, Novel Formulation Optimization, Chemical Process Optimization, Real-time Equipment Monitoring, Production Capacity Optimization, Pricing Optimization, Laboratory Automation, Others], By End-user [Chemical Processing Industry, Research & Development, Others], By Region, Opportunities and Forecast, 2016-2030F ... reactant configuration of four existing drugs Oteseconazole, Mitapivat, Tapinarof, and Mavacamten. The ... United States Generative AI in Chemical Market Assessment, By Model [Deep Learning, Natural Language Processing, Discriminative Model, Reinforcement Learning, Others], By Application [Complex Structure Predictions, Novel Formulation Optimization, Chemical Process Optimization, Real-time Equipment Monitoring, Production Capacity Optimization, Pricing Optimization, Laboratory Automation, Others], By End-user [Chemical Processing Industry, Research & Development, Others], By Region, Opportunities and Forecast, 2016-2030F ... reactant configuration of four existing drugs Oteseconazole, Mitapivat, Tapinarof, and Mavacamten. The ... Dermatophytic Onychomycosis Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Tablets, Nail Paints/Lacquers, Ointments & Creams, Laser Therapy Devices, Photodynamic Therapy (PDT) Solutions, and Other Product Types), Route of Administration, Treatment, Distribution Channel and By Geography ... rates. Newer agents like VT-1161 (oteseconazole) target fungal-specific enzymes, minimizing ... |